key: cord-0859551-o4bx60n0 authors: Rashidi, H. H.; Pepper, J.; Howard, T.; Klein, K.; May, L.; Albahra, S.; Phinney, B.; Salemi, M.; Tran, N. K. title: COMPARATIVE PERFORMANCE OF TWO AUTOMATED MACHINE LEARNING PLATFORMS FOR COVID-19 DETECTION BY MALDI-TOF-MS date: 2022-02-04 journal: nan DOI: 10.1101/2022.02.02.22270298 sha: 50160e1653e97506f8f22aef2c0d90f6bd139f83 doc_id: 859551 cord_uid: o4bx60n0 The 2019 novel coronavirus infectious disease (COVID-19) pandemic has resulted in an unsustainable need for diagnostic tests. Currently, molecular tests are the accepted standard for the detection of SARS-CoV-2. Mass spectrometry (MS) enhanced by machine learning (ML) has recently been postulated to serve as a rapid, high-throughput, and low-cost alternative to molecular methods. Automated ML is a novel approach that could move mass spectrometry techniques beyond the confines of traditional laboratory settings. However, it remains unknown how different automated ML platforms perform for COVID-19 MS analysis. To this end, the goal of our study is to compare algorithms produced by two commercial automated ML platforms (Platforms A and B). Our study consisted of MS data derived from 361 subjects with molecular confirmation of COVID-19 status including SARS-CoV-2 variants. The top optimized ML model with respect to positive percent agreement (PPA) within Platforms A and B exhibited an accuracy of 94.9%, PPA of 100%, negative percent agreement (NPA) of 93%, and an accuracy of 91.8%, PPA of 100%, and NPA of 89%, respectively. These results illustrate the MS methods robustness against SARS-CoV-2 variants and highlight similarities and differences in automated ML platforms in producing optimal predictive algorithms for a given dataset. The Interestingly, the sensitivity and specificity for MALDI-TOF-MS when detecting 89 COVID-19 in nasal swab samples is impacted by the shear complexity of the specimen 90 matrix. 3 Studies suggest that over 1,000 protein groups may be represented in 91 nasopharyngeal (NP) swab specimens when measured by MS techniques. 6 As such, the 92 differentiation of mass spectra between disease states is not feasible by the human eye . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.02.22270298 doi: medRxiv preprint 115 We conducted a retrospective study analyzing data from a COVID-19 clinical trial 116 comparing a MALDI-TOF-MS based approach against reverse transcription (RT) -117 polymerase chain reaction (PCR) (Figure 2) 165 the optimal hyperparameter combinations within these embedded supervised 166 algorithms/methods to build and analyze thousands of unique optimized models that are 167 then statistically assessed to identify the best performing model for one's given task. Within this study, the trial data was imported into Platform A with the outcome goal 169 of acquiring and evaluating the MS peak patterns observed that can then assess COVID- is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 4, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 4, 2022. As noted in Figure 1 , two randomly generated datasets were acquired for the ML Table 3 ). As the COVID-19 pandemic continues across the globe with highly populous but 284 less equipped (e.g., healthcare access, vaccine availability, testing capacity) countries 285 (e.g., India and Latin America) 13,14 being devastated by the new surges, and 286 simultaneously, as COVID-19 reservoirs continue to persist and new variants arise due 287 to vaccine hesitancy observed in more well-resourced nations 15-17 , alternatives to costly 288 and resource constrained molecular tests remain critically needed. To this end, due to the 289 continued threat of COVID-19, the global community requires a rapid, cost-effective, and 290 high throughput testing approach to limit transmission of COVID-19. 18 Molecular methods 291 such as RT-PCR are known to be very sensitive and specific, however, high throughput 292 platforms perform testing in batches-requiring hours or days to produce results. 3,19 Ultra-293 fast RT-PCR methods are now available including at the point of care; however, these 294 platforms are limited to testing one sample at a time. 19 Antigen approaches provide a low-295 cost alternative to molecular methods; however, sensitivity and specificity suffers, 296 especially for asymptomatic populations. 20 The use of AutoML with MALDI-TOF-MS for . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.02.22270298 doi: medRxiv preprint 297 COVID-19 screening is an innovative rapid and high-throughput approach at overcoming 298 limitations inherent with molecular-or antigen-based approaches (Tran 2021 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.02.22270298 doi: medRxiv preprint perspectives on trustworthiness, explainability, usability, and transparency. Digital Med 2020;47:1-5. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.02.22270298 doi: medRxiv preprint Table 1 350 2. World Health Organization, COVID-19 Variant Tracking Novel Application of Automated Machine Learning 354 With Maldi-Tof-Ms For Rapid High-Throughput Screening of Covid-19 Detection of SARS-CoV-2 in nasal 357 swabs using MALDI-MS MALDI-TOF-MS for the diagnosis of infectious diseases Proteotyping SARS-CoV-2 virus from 361 nasopharyngeal swabs: A proof-of-concept focused on a 3 min mass spectrometry 362 window Potential biases in machine learning 368 algorithms using electronic health record data Evolution and impact of bias in human and machine 371 learning algorithm interaction Artificial Intelligence and Machine Learning 373 in Pathology: The Present Landscape of Supervised Methods Food and Drug Administration Policy for Coronavirus Disease-2019 Tests During the 376 Public Health Emergency (Revised Machine learning at Microsoft with ML.NET Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Association for Computing Machinery A comprehensive review of COVID-19 in India: A frequent 383 catch of information Challenges in ensuring global 387 access to COVID-19 vaccines: production, affordability, allocation, and development COVID-19 and vaccine hesitancy: A challenge the 390 United States must overcome COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of 392 Vaccine Acceptance Rates COVID-19 test sensitivity -a strategy for containment. N Engl 394 Clinical performance of the point-of-care cobas 396 Liat for detection of SARS-CoV-2 in 20 minutes: A multicenter study Comparative cost-effectiveness of SARS-CoV-2 testing 399 strategies in the USA: A modelling study Enhancing Military Burn-and Trauma-401 Related Acute Kidney Injury Prediction Through an Automated Machine Learning 402 Platform and Point-of-Care Testing Novel application of an automated-machine 405 learning development tool for predicting burn sepsis: proof of concept. Nature's Sci 406 Rep Allyson Sage, and Mr. Scott 411 Bainbridge for his support of this study. The project was developed jointly between UC LBFGS-Logistic Regression # 25% of the features selected were from an ANOVA-based Select percentile unsupervised feature selection approach ## 75% of the features selected were from an Random Forest-based Importances unsupervised feature selection approach SGD SDCA (Stochastic Dual Coordinate Ascent) LBFGS (Limited-memory Broyden-Fletcher-Goldfarb-Shanno)